FindTrial
Sign In

N/A - GEMRITUX

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-000221-68-FR
Enrollment
Unknown
Registered
2011-05-31
Start date
2013-06-13
Completion date
Unknown
Last updated
2013-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 13.1 Level: PT Classification code 10018364 Term: Glomerulonephritis System Organ Class: 10038359 - Renal and urinary disorders

Interventions

Trade Name: Mabthera Product Name: Mabthera Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: Rituximab Other descriptive name: Mabthera Concentration unit: mg milligram

Sponsors

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 80 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026